Comparison of the Efficacy of Innovator Rituximab and its Biosimilars in Diffuse Large B Cell Lymphoma Patients: A Retrospective Analysis

Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma among adults, although it also affects the young and the elderly. DLBCL is treated with a chimeric monoclonal antibody against CD20, a B cell surface protein, named rituximab, in combination with a multidrug chemot...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Indian J Hematol Blood Transfus
Päätekijät: Bankar, Aniket, Korula, Anu, Abraham, Aby, Viswabandya, Auro, George, Biju, Srivastava, Alok, Mathews, Vikram
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer India 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042466/
https://ncbi.nlm.nih.gov/pubmed/32174693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-019-01167-w
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia